Session 1: The Opioid Crisis: Current Status and Treatment Responses (2.25 CME)
Session 1 examines several topics in the field of opioid-related morbidity and mortality, as well as the treatment of opioid use disorder. Presenters will dive into updates on opioid misuse, overdose epidemiology, and current national trends. This will be followed by an updated review of evidence-based strategies for opioid overdose prevention, and an overview of data that are the basis of current approaches for the investigation of novel kappa-opioid receptor ligands for the treatment of opioid use disorder. Finally, we will close with a review of recent clinical trials examining the efficacy and effectiveness of extended-release (XR) medications for the treatment of opioid use disorder. Richard C. Dart, MD, PhD, Alexander Y. Walley, MD, MSc, FSAM, Eduardo R. Butelman, PhD, and Joshua D. Lee, MD, MSc bring their years of experience and expertise to deliver an exceptional presentation covering the following: Opioid Epidemiology in the Age of Fentanyl, Opioid Overdose Prevention and Management in a Dynamic Opioid Crisis, Targeting the Kappa-Opioid Receptor System for Developing New Pharmacotherapies for Opioid Use Disorder, and Long-Acting Naltrexone and Buprenorphine Formulations: Efficacy Effectiveness and Comparative Effectiveness.